Aaron Davenport
SK Capital Partners
Group governance
Supervisory board
The Supervisory Board is a non-executive Board, responsible for supervising and controlling the activity of the Management Board and the CEO in order to ensure Seqens’ long-term sustainability. To manage certain areas of focus, the Supervisory Board has implemented 3 specific committees.
Supervisory board
Jamshid Keynejad
SK Capital Partners
Daniele Ferrari
SK Capital Partners
Jayesh Taunk
SK Capital Partners
Stephen Fargis
Bpifrance
Dina Bouzoubaa
Bpifrance
Samantha Schwartz
Nov Santé
Frédéric Collard
Ardian
Thierry Chignon
Mérieux Development
3 committees for a greater ability to act
- The Audit committee helps board members fulfil their responsibilities in terms of producing and controlling financial information, risk management and external audits.
- The Corporate Social Responsibility committee provides expertise and recommendations on Novacap CSR strategy and actions.
- The Human Resources committee is responsible for assisting board members and advising them on the appointment and remuneration of Novacap’s key managers.
Executive committee
The Executive Committee comprises 14 members and is chaired by Pierre Luzeau. Its mission is to steer the strategic roadmap defined with the Supervisory Board to meet the group’s improvement and development objectives.
Pierre Luzeau
Seqens - Chief Executive Officer
Executive committee
Vincent Milhau
Seqens - Chief Financial Officer
Jean-Louis Martin
Seqens - VP HR & Industrial
Philippe Clavel
Seqens - VP Pharmaceutical solutions
Laurent Castor
Seqens - VP Specialty Ingredients
Helen Webster
Seqens - Custom Specialties Managing Director
Robert Monti
Seqens - Essential Drug Substances DS Managing Director
Christophe Eychenne-Baron
Seqens - Group R&D Director
Gildas Barreyre
Seqens - ExCo General Secretary
Candice Du Chayla
Seqens - Communication Director
Tristan Chabanis
Seqens - Group Controlling Director
Stéphanie Girard
Seqens - Quality & Regulatory Director
Ludovic Lyonnet
Seqens - SPS Managing Director
Elise Bordet
Seqens - Strategy Director
Sébastien Taillemite
Seqens - Advanced Specialties Managing Director
Executive committee's missions
-
Developing and protecting Seqens’ strategy, values and assets: its missions include formulating and implementing the group’s strategic vision and objectives. The ExCo also steers the group’s business portfolio and is responsible for fulfilling the group’s objectives of creating value.
-
Managing performance: within his/her scope, each ExCo member manages the performance of business units or function leaders, allocating group-wide resources and governing the group’s activities.